Health & Happiness (1112): GEM Fund Positioning Update
On the back of the Henry Soediarko piece entitled Health & Happiness (1112): Buy - Unjustly Punished!, here is a brief update on positioning...
471 Views
Health & Happiness (1112): Buy - Unjustly Punished!
Health And Happiness (H&H) (1112 HK) 1H 2019 result was better than its Australian competitor, Bellamy, whose product is perceived to be...
539 Views
Asia HY Monthly - Chinese Property Update - Lucror Analytics
In this month’s “In-Focus” section, we provide an update on the Chinese property sector, including trends in contracted sales and operations, as...
89 Views
China Feihe (中国飞鹤) IPO: Thoughts on Valuation
China Feihe, a leading infant milk formula (IMF) manufacturer in China, is planning to raise up to USD 1 billion to list in Hong Kong, two years...
732 Views
Asia HY Trade Recommendations - August 2019 - Lucror Analytics
The Asia HY Trade Recommendations report for August includes a summary of our recommendations, as well as our high-conviction ideas. We also...
75 Views